Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024)

Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Avalo Therapeutics 1.04 Mn 1.04 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.77 Mn
Dec 31, 2023 78,478.00
Sep 30, 2023 -94,107.00
Jun 30, 2023 82,161.00
Dec 31, 2021 -3,531.00
Sep 30, 2021 357.00
Jun 30, 2021 2,447.00
Mar 31, 2021 -5,574.00
Dec 31, 2020 5,116.00
Sep 30, 2020 1,618.00
Jun 30, 2020 -7,170.00
Mar 31, 2020 -14,558.00
Dec 31, 2019 23,261.00
Sep 30, 2019 21,344.00
Jun 30, 2019 -17,383.00
Mar 31, 2019 -10,131.00
Dec 31, 2018 61,612.00
Sep 30, 2018 -47,822.00
Jun 30, 2018 -3,893.00
Mar 31, 2018 7,516.00